STAT+: Pharmalittle: We’re reading about the FDA warning Novo Nordisk, Lilly investing in China, and more
STAT [Unofficial]
March 11, 2026
The Trump administration push for lower U.S. drug prices helped Astellas secure higher pricing for its new eye medicine in Japan
Discussion in the ATmosphere